Investors sold shares of Colgate-Palmolive (NYSE:CL) on strength during trading on Monday. $31.37 million flowed into the stock on the tick-up and $138.52 million flowed out of the stock on the tick-down, for a money net flow of $107.15 million out of the stock. Of all stocks tracked, Colgate-Palmolive had the 9th highest net out-flow for the day. Colgate-Palmolive traded up $0.24 for the day and closed at $71.46
A number of brokerages have recently issued reports on CL. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research report on Monday, October 23rd. Deutsche Bank began coverage on Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price on the stock. Jefferies Group decreased their target price on Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating on the stock in a research report on Monday, October 30th. Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the company a “hold” rating in a research report on Sunday, October 29th. Finally, KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $77.91.
The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 27.02. The firm has a market cap of $62,750.00, a P/E ratio of 27.59, a P/E/G ratio of 2.65 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same period in the prior year, the company earned $0.75 EPS. The firm’s revenue was up 4.6% compared to the same quarter last year. equities analysts anticipate that Colgate-Palmolive will post 3.18 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.24%. The ex-dividend date was Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.
In other Colgate-Palmolive news, SVP John J. Huston sold 14,000 shares of the firm’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $69.44, for a total value of $972,160.00. Following the completion of the sale, the senior vice president now directly owns 100,508 shares of the company’s stock, valued at approximately $6,979,275.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Henning I. Jakobsen sold 36,215 shares of the firm’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $71.22, for a total value of $2,579,232.30. Following the completion of the sale, the vice president now directly owns 70,783 shares of the company’s stock, valued at $5,041,165.26. The disclosure for this sale can be found here. Over the last three months, insiders sold 421,019 shares of company stock valued at $30,031,097. 1.02% of the stock is owned by corporate insiders.
Several institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Colgate-Palmolive by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after acquiring an additional 1,621,392 shares during the last quarter. BlackRock Inc. increased its position in shares of Colgate-Palmolive by 1.4% during the 4th quarter. BlackRock Inc. now owns 52,360,691 shares of the company’s stock worth $3,950,614,000 after purchasing an additional 711,972 shares during the last quarter. Renaissance Technologies LLC increased its position in shares of Colgate-Palmolive by 42.4% during the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after purchasing an additional 2,903,800 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Colgate-Palmolive by 2.1% during the 4th quarter. Geode Capital Management LLC now owns 8,975,479 shares of the company’s stock worth $675,751,000 after purchasing an additional 188,455 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its position in shares of Colgate-Palmolive by 25.3% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock worth $508,111,000 after purchasing an additional 1,385,946 shares during the last quarter. 71.52% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.